Chronic liver injury induced by drugs and toxins

Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements

(2017) Herbert L. Bonkovsky et al.   HEPATOLOGY

Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole

(2017) Zonghao Zhao et al.   MEDICINE

Drug-induced steatohepatitis

(2016) Ajit Dash et al.   Expert Opinion on Drug Metabolism & Toxicology

Autoimmune-like drug-induced liver injury: a review and update for the clinician

(2016) Jonathan G. Stine et al.   Expert Opinion on Drug Metabolism & Toxicology

Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury

(2016) Inmaculada Medina-Caliz et al.   JOURNAL OF HEPATOLOGY

Persistent Liver Biochemistry Abnormalities Are More Common in Older Patients and those With Cholestatic Drug Induced Liver Injury

(2015) Robert J Fontana et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Drug-induced fatty liver disease: An overview of pathogenesis and management

(2015) Sanjaya Satapathy et al.   Annals of Hepatology

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study

(2015) Naga Chalasani et al.   GASTROENTEROLOGY

P1097 : Distinguishing drug induced autoimmune hepatitis from idiopatic autoimmune hepatitis

(2015) A. Ortega-Alonso et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines: Autoimmune hepatitis

(2015)   JOURNAL OF HEPATOLOGY

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

(2015)   JOURNAL OF HEPATOLOGY

Chronic liver injury induced by drugs: a systematic review

(2015) Jonathan G. Stine et al.   LIVER INTERNATIONAL

Peliosis hepatis: Personal experience and literature review

(2015) Daniele Crocetti   WORLD JOURNAL OF GASTROENTEROLOGY

Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease

(2015) Liane Rabinowich et al.   Biomed Research International

End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndrome

(2014) M. F. Dawwas et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

(2014) Naga P Chalasani et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: A retrospective cohort study

(2014) Anna Licata et al.   DIGESTIVE AND LIVER DISEASE

Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset

(2014) Robert J. Fontana et al.   GASTROENTEROLOGY

Drug-Induced Nodular Regenerative Hyperplasia

(2014) Marwan Ghabril et al.   SEMINARS IN LIVER DISEASE

Drug-Induced Hepatic Steatosis

(2014) Naga Chalasani et al.   SEMINARS IN LIVER DISEASE

Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases

(2013) Marwan Ghabril et al.   Clinical Gastroenterology and Hepatology

Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

(2011) G P Aithal et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Drug-Induced Autoimmune-Like Hepatitis: A Diagnostic Challenge

(2011) Agustin Castiella et al.   DIGESTIVE DISEASES AND SCIENCES

The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury

(2011) Ayako Suzuki et al.   HEPATOLOGY

Hepatotoxicity related to antirheumatic drugs

(2011) Guruprasad P. Aithal   Nature Reviews Rheumatology

Nodular regenerative hyperplasia: Evolving concepts on underdiagnosed cause of portal hypertension

(2011) Marek Hartleb   WORLD JOURNAL OF GASTROENTEROLOGY

Secondary causes of nonalcoholic fatty liver disease

(2011) Jacob M. Kneeman et al.   Therapeutic Advances in Gastroenterology

Drug-induced autoimmune hepatitis: Clinical characteristics and prognosis

(2010) Einar Björnsson et al.   HEPATOLOGY

Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis

(2010) Laura Rubbia-Brandt et al.   HISTOPATHOLOGY

Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease

(2010) Emma Calabrese et al.   Journal of Crohns & Colitis

Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: A case–control study

(2010) David Laharie et al.   JOURNAL OF HEPATOLOGY

Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis

(2009) Cátia C.P. Aires et al.   BIOCHEMICAL PHARMACOLOGY

The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer

(2009) Tom Saphner et al.   CANCER

Portal Hypertension Associated With Oxaliplatin Administration: Clinical Manifestations of Hepatic Sinusoidal Injury

(2009) Julian H. Slade et al.   Clinical Colorectal Cancer

Drug-Induced Steatohepatitis Leading to Cirrhosis: Long-Term Toxicity of Amiodarone Use

(2009) Kaiser Raja et al.   SEMINARS IN LIVER DISEASE

Vanishing Bile Duct Syndrome

(2008) Nancy S. Reau et al.   Clinics in Liver Disease

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

(2008) Naga Chalasani et al.   GASTROENTEROLOGY

The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice

(2008) Einar Björnsson et al.   JOURNAL OF HEPATOLOGY